Verizon to cut 15,000 jobs amid growing competition pressures - WSJ
Three 10% owners of Marpai, Inc. (NASDAQ:MRAI), Intelligent Fanatics Capital Management LLC, Cassel Ian J., and IFCM MicroCap Fund LP, reported selling shares of common stock between August 13 and October 6, 2025. The micro-cap healthcare technology company, currently valued at $24.7 million, has seen its stock surge 145% over the past year despite showing weak financial health indicators according to InvestingPro analysis. The sales amounted to a total of $270,640, with prices ranging from $1.40 to $1.63 per share.
The entities sold a combined total of 194,000 shares in multiple transactions.
In other recent news, Marpai , Inc. announced a significant investment from HillCour Investment Fund, LLC, which is controlled by the company’s CEO, Damien Lamendola. The investment amounts to $200,000 and involves the purchase of 147,058 shares of common stock at $1.36 per share. This development is expected to support Marpai’s general corporate purposes, including the acceleration of advanced product offerings and the expansion of its technology platform. Additionally, the company aims to increase its market penetration among self-funded employer groups. These recent developments highlight Marpai’s strategic efforts to enhance its position in the market and further its growth initiatives.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.